Giró-Perafita, A.; Rabionet, M.; Planas, M.; Feliu, L.; Ciurana, J.; Ruiz-MartÃnez, S.; Puig, T.
EGCG-Derivative G28 Shows High Efficacy Inhibiting the Mammosphere-Forming Capacity of Sensitive and Resistant TNBC Models. Molecules 2019, 24, 1027.
https://doi.org/10.3390/molecules24061027
AMA Style
Giró-Perafita A, Rabionet M, Planas M, Feliu L, Ciurana J, Ruiz-MartÃnez S, Puig T.
EGCG-Derivative G28 Shows High Efficacy Inhibiting the Mammosphere-Forming Capacity of Sensitive and Resistant TNBC Models. Molecules. 2019; 24(6):1027.
https://doi.org/10.3390/molecules24061027
Chicago/Turabian Style
Giró-Perafita, Ariadna, Marc Rabionet, Marta Planas, Lidia Feliu, Joaquim Ciurana, Santiago Ruiz-MartÃnez, and Teresa Puig.
2019. "EGCG-Derivative G28 Shows High Efficacy Inhibiting the Mammosphere-Forming Capacity of Sensitive and Resistant TNBC Models" Molecules 24, no. 6: 1027.
https://doi.org/10.3390/molecules24061027
APA Style
Giró-Perafita, A., Rabionet, M., Planas, M., Feliu, L., Ciurana, J., Ruiz-MartÃnez, S., & Puig, T.
(2019). EGCG-Derivative G28 Shows High Efficacy Inhibiting the Mammosphere-Forming Capacity of Sensitive and Resistant TNBC Models. Molecules, 24(6), 1027.
https://doi.org/10.3390/molecules24061027